Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22)

Journal of Nephrology

Volumn 28, Issue 2, 2015, Pages 201-207

  Alkhalaf, A ^a   Landman, G W D ^a,e   van Hateren, K J J ^a   Groenier, K H ^a,b   Mooyaart, A L ^c   De Heer, E ^c   Gans, R O B ^b   Navis, G J ^b   Bakker, S J L ^b   Kleefstra, N ^a,b,d   Bilo, H J G ^a,b  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^e GELRE HOSPITALS   (Netherlands)

Author keywords

5 Leucine repeat; Cardiovascular mortality; Carnosinase gene; CNDP1; Renal function; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; LEUCINE; CNDP1 PROTEIN, HUMAN; DIPEPTIDASE;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CNDP1 GENE; CREATININE BLOOD LEVEL; DISEASE DURATION; FEMALE; FOLLOW UP; GENE; GENE INTERACTION; GENETIC POLYMORPHISM; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RISK FACTOR; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DISEASE COURSE; GENETICS; HOMOZYGOTE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIPEPTIDASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOMOZYGOTE; HUMANS; LEUCINE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 84925940723     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0096-6     Document Type: Article

References (25)

1. Parving HH, Osterby R, Ritz E (2000) Diabetic nephropathy. In: Brenner BM (ed) The kidney. WB Saunders, Philadelphia, pp 1713–1773
2. Fava S, Hattersley AT (2002) The role of genetic susceptibility in diabetic nephropathy: evidence from family studies. Nephrol Dial Transpl 17(9):1543–1546
3. Vardarli I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, Basci A, Bartram CR, van der Woude FJ, Janssen B (2002) Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int 62(6):2176–2183
4. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, Ipp E, Kao WH, Kimmel PL, Klag MJ, Knowler WC, Meoni LA, Nelson RG, Nicholas SB, Pahl MV, Parekh RS, Quade SR, Rich SS, Rotter JI, Scavini M, Schelling JR, Sedor JR, Sehgal AR, Shah VO, Smith MW, Taylor KD, Winkler CA, Zager PG, Freedman BI, Family Investigation of Nephropathy Diabetes Research Group (2007) Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 56(6):1577–1585. doi:10.2337/db06-1154
5. Teufel M, Saudek V, Ledig JP, Bernhardt A, Boularand S, Carreau A, Cairns NJ, Carter C, Cowley DJ, Duverger D, Ganzhorn AJ, Guenet C, Heintzelmann B, Laucher V, Sauvage C, Smirnova T (2003) Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. J Biol Chem 278(8):6521–6531. doi:10.1074/jbc.M209764200
6. Mooyaart AL, van Valkengoed IG, Shaw PK, Peters V, Baelde HJ, Rabelink TJ, Bruijn JA, Stronks K, de Heer E (2009) Lower frequency of the 5/5 homozygous CNDP1 genotype in South Asian Surinamese. Diabetes Res Clin Pract 85(3):272–278
7. Janssen B, Hohenadel D, Brinkkoetter P, Peters V, Rind N, Fischer C, Rychlik I, Cerna M, Romzova M, de Heer E, Baelde H, Bakker SJ, Zirie M, Rondeau E, Mathieson P, Saleem MA, Meyer J, Koppel H, Sauerhoefer S, Bartram CR, Nawroth P, Hammes HP, Yard BA, Zschocke J, van der Woude FJ (2005) Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 54(8):2320–2327
8. Hipkiss AR, Worthington VC, Himsworth DT, Herwig W (1998) Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. Biochimica et biophysica acta 1380(1):46–54
9. Freedman BI, Hicks PJ, Sale MM, Pierson ED, Langefeld CD, Rich SS, Xu J, McDonough C, Janssen B, Yard BA, van der Woude FJ, Bowden DW (2007) A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol Dial Transpl 22(4):1131–1135
10. Mooyaart AL, Zutinic A, Bakker SJ, Grootendorst DC, Kleefstra N, van Valkengoed V, Bohringer S, Bilo HJ, Dekker FW, Bruijn JA, Navis G, Janssen B, Baelde HJ, de Heer E (2010) Association between CNDP1 genotype and diabetic nephropathy is sex-specific. Diabetes 59:1555–1559
11. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Rischen RO, Meyboom-de Jong B (2005) Shared care with task delegation to nurses for type 2 diabetes: prospective observational study. Neth J Med 63(3):103–110
12. Bartels H, Bohmer M, Heierli C (1972) Serum creatinine determination without protein precipitation. Clinica chimica acta 37:193–197
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470
14. Wanic K, Placha G, Dunn J, Smiles A, Warram JH, Krolewski AS (2008) Exclusion of polymorphisms in carnosinase genes (CNDP1 & CNDP2) as cause of diabetic nephropathy in type 1 diabetes mellitus. Results of large case–control and follow-up studies. Diabetes 57:2547–2551
15. Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, Postmus D, Forsblom C, Groop PH, Vionnet N, Hadjadj S, Marre M, Parving HH, Rossing P, Tarnow L (2010) A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus. Diabetologia 53(12):2562–2568. doi:10.1007/s00125-010-1863-0
16. Therneau TM, Grambsch PM (2000) Modeling survival data: extending the Cox model. Springer, Rochester, pp 127–152
17. Riedl E, Koeppel H, Pfister F, Peters V, Sauerhoefer S, Sternik P, Brinkkoetter P, Zentgraf H, Navis G, Henning R, Van Den BJ, Bakker S, Janssen B, van der WF, Yard B (2010) N-Glycosylation of carnosinase influences protein secretion and enzyme activity: implications for hyperglycemia. Diabetes 59:1984–1990
18. Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ (Clinical research ed) 300(6719):230–235
19. McDonough CW, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW (2009) The influence of carnosinase gene polymorphisms on diabetic nephropathy risk in African-Americans. Human genetics 126(2):265–275
20. Ahluwalia TS, Lindholm E, Groop LC (2011) Common variants in CNDP1 and CNDP2, and risk of nephropathy in type 2 diabetes. Diabetologia 54(9):2295–2302. doi:10.1007/s00125-011-2178-5
21. Riedl E, Koeppel H, Brinkkoetter P, Sternik P, Steinbeisser H, Sauerhoefer S, Janssen B, van der Woude FJ, Yard BA (2007) A CTG polymorphism in the CNDP1 gene determines the secretion of serum carnosinase in Cos-7 transfected cells. Diabetes 56(9):2410–2413
22. Everaert I, Mooyaart A, Baguet A, Zutinic A, Baelde H, Achten E, Taes Y, De Heer E, Derave W (2011) Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans. Amino Acids 40(4):1221–1229. doi:10.1007/s00726-010-0749-2
23. Zschocke J, Nebel A, Wicks K, Peters V, El Mokhtari NE, Krawczak M, van der Woude F, Janssen B, Schreiber S (2006) Allelic variation in the CNDP1 gene and its lack of association with longevity and coronary heart disease. Mech Ageing Dev 127(11):817–820
24. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS, Chronic Kidney Disease Prognosis C (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307(18):1941–1951. doi:10.1001/jama.2012.3954
25. Tent H, Waanders F, Krikken JA, Lambers Heerspink HJ, Stevens LA, Laverman GD, Navis G (2011) Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease. Nephrol Dial Transpl. doi:10.1093/ndt/gfr235